Lucira_COVID-19_&_Flu_Home_Test_packaging_and_device
Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
March 28, 2023 08:05 ET | Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
Prolocor Logo
Prolocor Announces a Combined $5.2 Million in Funding From Seed Round and NIH SBIR Grant
August 16, 2022 09:00 ET | Prolocor Inc
PHILADELPHIA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by...
Lucira COVID-19 & Flu Test – the 99% Accurate At-Home Test for Covid and Flu
Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test
August 11, 2022 07:01 ET | Lucira Health Inc.
EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and...
Prolocor Logo
Prolocor to Participate at Biotech Showcase 2022
January 10, 2022 09:00 ET | Prolocor Inc
PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prolocor Inc, a healthcare startup developing an innovative precision diagnostic test that quantifies FcγRIIa on the surface of platelets, today...
TIP_link_300x300.jpg
Virology Market Valuation to Outstrip $5.27Bn by 2028 Growth Projection at 3.6% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
September 21, 2021 08:51 ET | The Insight Partners
New York, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Virology Market: Key InsightsAccording to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type,...
ScipherTM.png
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
February 11, 2021 08:00 ET | Scipher Medicine Corporation
WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with WellDyne, a...